Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Halozyme Therapeutics
HALO
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 52.88%270.64M | -148.77%-128.31M | 424.67%275.36M | 151.58%65.75M | -54.17%57.85M | 646.73%177.03M | 1,381.14%263.08M | -125.88%-84.81M | -502.01%-127.47M | 174.06%126.23M |
Net interest income | -4.13%228.43M | -7.57%56.36M | -16.13%53.84M | -2.17%56.21M | 11.48%62.02M | 34.19%238.26M | -33.43%60.97M | 115.52%64.2M | 44.56%57.45M | 60.09%55.64M |
-Net interest income | 16.99%1.91B | 3.08%473.71M | 10.43%490.69M | 15.38%478.43M | 49.01%464.3M | 81.75%1.63B | 48.62%459.58M | 92.00%444.32M | 116.68%414.66M | 88.98%311.59M |
-Interest income from loans and lease | 16.86%1.89B | 2.83%470.07M | 10.56%486.35M | 15.26%474.25M | 48.64%460.03M | 81.62%1.62B | 48.17%457.12M | 92.18%439.88M | 116.83%411.46M | 89.07%309.49M |
-Other interest income | 34.72%16.43M | 48.15%3.64M | -2.32%4.34M | 30.56%4.18M | 104.02%4.27M | 101.94%12.19M | 242.48%2.46M | 75.82%4.44M | 98.88%3.2M | 76.60%2.09M |
-Total interest expense | 20.61%1.68B | 4.70%417.35M | 14.92%436.85M | 18.20%422.22M | 57.17%402.28M | 93.50%1.39B | 83.16%398.6M | 88.52%380.13M | 135.58%357.21M | 96.70%255.95M |
-Interest expense for long term debt and capital securities | 20.30%1.64B | 3.44%404.03M | 14.60%426.84M | 18.03%412.62M | 66.56%373.74M | 126.57%1.36B | 113.40%390.57M | 121.57%372.46M | 180.56%349.58M | 110.41%224.39M |
-Other interest expense | 34.06%41.41M | 65.85%13.32M | 30.53%10.01M | 25.93%9.61M | -9.55%28.54M | -73.97%30.89M | -76.79%8.03M | -77.14%7.67M | -71.77%7.63M | 34.40%31.56M |
Non interest income | 168.94%42.21M | -191.37%-184.67M | 248.66%221.51M | 105.16%9.54M | -105.91%-4.17M | 70.83%-61.23M | 280.24%202.11M | -121.29%-149.01M | -203.57%-184.92M | 524.52%70.59M |
-Fees and commissions | -178.04%-38.28M | -506.02%-15.61M | -470.06%-6.66M | -209.73%-5.41M | 103.37%131K | -266.45%-13.77M | 95.97%-2.58M | -111.45%-1.17M | -125.56%-1.75M | -107.04%-3.89M |
-Gain loss on sale of assets | 269.61%80.5M | -182.59%-169.06M | 254.34%228.18M | 108.16%14.95M | -105.78%-4.3M | 78.25%-47.46M | 524.85%204.69M | -90.64%-147.84M | -170.34%-183.17M | 269.76%74.47M |
Credit losses provision | ||||||||||
Non interest expense | -15.20%271.83M | -18.12%64.12M | -23.14%65.17M | -22.75%70.03M | 8.52%72.51M | 1.97%320.57M | 1,004.05%78.31M | -6.76%84.8M | -15.70%90.65M | -35.86%66.82M |
Occupancy and equipment | -43.91%4.9M | ---- | ---- | ---- | ---- | 22.88%8.74M | ---- | ---- | ---- | ---- |
Professional expense and contract services expense | -17.39%20.48M | ---- | ---- | ---- | ---- | -1.81%24.79M | ---- | ---- | ---- | ---- |
Selling and administrative expenses | -18.16%211.87M | -20.26%29.25M | -31.18%55.81M | -24.45%62M | 9.76%64.81M | 0.07%258.89M | 169.15%36.68M | -10.66%81.1M | -26.15%82.06M | -43.88%59.04M |
-General and administrative expense | -24.03%172.44M | -28.15%19.36M | -34.65%45.49M | -30.06%51.29M | -1.39%56.29M | -7.60%226.99M | 140.79%26.95M | -23.31%69.61M | -34.00%73.34M | -45.74%57.09M |
-Selling and marketing expense | 23.62%39.43M | 1.60%9.89M | -10.15%10.33M | 22.79%10.71M | 335.17%8.51M | 144.77%31.9M | --9.73M | --11.49M | --8.72M | --1.96M |
Depreciation amortization depletion | -8.08%38.95M | -2.00%9.74M | -1.78%9.78M | -21.17%9.75M | -4.23%9.68M | 0.81%42.37M | --9.94M | --9.95M | --12.37M | --10.11M |
-Depreciation and amortization | -8.08%38.95M | -2.00%9.74M | -1.78%9.78M | -21.17%9.75M | -4.23%9.68M | 0.81%42.37M | --9.94M | --9.95M | --12.37M | --10.11M |
Other non-interest expense | 69.28%-4.37M | 86.36%-251K | 93.32%-418K | 54.43%-1.72M | 15.39%-1.97M | 24.04%-14.21M | 79.07%-1.84M | -344.60%-6.26M | 28.47%-3.78M | 27.68%-2.33M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 316.66%50.94M | 626.10%55.65M | 93.87%-418K | 54.43%-1.72M | -10.33%-2.57M | 16.75%-23.51M | 27.15%-10.58M | -30.91%-6.82M | 28.47%-3.78M | 27.68%-2.33M |
Less:Impairment of capital assets | -90.42%891K | ---- | ---- | ---- | --600K | -2.43%9.3M | ---- | ---- | ---- | --0 |
Less:Other special charges | -69.28%4.37M | -86.36%251K | -93.32%418K | -54.43%1.72M | -15.39%1.97M | -24.04%14.21M | -79.07%1.84M | 344.60%6.26M | -28.47%3.78M | -27.68%2.33M |
Write off | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --558K | --0 | ---- |
Gain on extinguishment of debt | ---56.19M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -3,384.83%-6.93M | -241.99%-9.03M | -141.32%-1.59M | 215.64%2.24M | 55.24%1.45M | -99.34%211K | 52.96%-2.64M | -81.18%3.85M | -113.69%-1.94M | -68.63%936K |
Income before tax | 125.66%42.82M | -184.99%-145.81M | 220.63%208.17M | 98.32%-3.77M | -127.20%-15.78M | 51.36%-166.84M | 459.18%171.55M | -52.41%-172.57M | -86.78%-223.84M | 199.41%58.01M |
Income tax | 504.38%2.4M | -1,747.67%-3.18M | 4,396.12%4.43M | 135.86%1.15M | 0 | 96.54%-593K | -84.95%193K | 98.79%-103K | -46.07%-3.22M | 132.79%2.53M |
Earnings from equity interest net of tax | ||||||||||
Net income | 116.36%35.69M | -186.62%-142.63M | 216.47%203.75M | 97.70%-5.12M | -239.14%-20.3M | 69.51%-218.16M | 190.47%164.66M | 42.02%-174.93M | -32.57%-222.48M | 122.80%14.59M |
Net Income continuous operations | 124.31%40.42M | -183.23%-142.63M | 218.14%203.75M | 97.77%-4.92M | -128.44%-15.78M | 48.98%-166.25M | 449.40%171.36M | -64.66%-172.47M | -87.54%-220.62M | 209.56%55.48M |
Net income discontinuous operations | 90.89%-4.73M | --0 | --0 | 89.07%-203K | 88.94%-4.52M | 86.68%-51.91M | 94.96%-6.7M | 98.75%-2.46M | 96.30%-1.86M | -206.15%-40.89M |
Minority interest income | 114.63%20.2M | -180.87%-83.54M | 209.10%119.55M | 97.88%-3.04M | -210.64%-12.77M | 73.69%-138.07M | 182.65%103.3M | 49.56%-109.57M | -12.74%-143.34M | 120.79%11.54M |
Net income attributable to the parent company | 119.34%15.49M | -196.30%-59.09M | 228.82%84.2M | 97.36%-2.09M | -346.82%-7.54M | 58.00%-80.09M | 207.61%61.36M | 22.63%-65.36M | -94.54%-79.14M | 135.96%3.05M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 119.34%15.49M | -196.30%-59.09M | 228.82%84.2M | 97.36%-2.09M | -346.82%-7.54M | 58.00%-80.09M | 207.61%61.36M | 22.63%-65.36M | -94.54%-79.14M | 135.96%3.05M |
Basic earnings per share | 116.07%1.57 | -186.23%-5.95 | 213.83%8.48 | 97.68%-0.21 | -260.00%-0.8 | 68.07%-9.77 | 176.67%6.9 | 44.81%-7.45 | -39.23%-9.05 | 135.71%0.5 |
Diluted earnings per share | 112.08%1.18 | -212.26%-5.95 | 200.67%7.5 | 96.69%-0.3 | -260.00%-0.8 | 68.69%-9.77 | 158.89%5.3 | 44.81%-7.45 | -29.29%-9.05 | 116.67%0.5 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |